Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
20 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Intuitive Surgical reported Q3 2026 revenue growth of 22% to over $3 billion, alongside 15% growth in total procedures and 28% growth in da Vinci system placements. The company also plans to reduce da Vinci instruments and accessories revenue per procedure by 3% to 5%.
Johnson & Johnson reported third-quarter operational sales growth of 6% and revenue above $25 billion. The company raised its full-year 2026 operational sales growth outlook to 6.7%–7.1%.
For best results when printing this announcement, please click on link below: Johnson & Johnson reports Q3 2026 results, raises 2026 guidance 2026 Third-Quarter reported sales growth of 5.9% to $25.4 Billion with operational growth of 6.0%* and adjusted operational growth of 6.1% 2026 Third-Quarter earnings per share (
Profound Medical (TSX: PRN ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Profound Medical reported
On Thursday, Lineage Cell Therapeutics (AMEX: LCTX ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Lineage Ce
ResMed (NYSE: RMD ) reported fourth-quarter financial results on Thursday. The transcript from the company's fourth-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary ResMed Inc reported a strong
On Thursday, Globus Medical (NYSE: GMED ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Globus Medical reported Q2 2026 reven
Medincell said its partner Teva announced U.S. FDA approval of WELTRUZA, an extended-release injectable suspension of olanzapine for adults with schizophrenia. Teva plans to make the treatment available in the United States in the coming weeks.
Eli Lilly (NYSE: LLY ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Full Transcript OPERATOR Ladies and gentlemen, thank you f
AngioDynamics (NASDAQ: ANGO ) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Angi
Teleflex (NYSE: TFX ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at
Vystar said it completed the formation of the new operating corporation for R3ALM and appointed a joint board of directors. It also said the platform is moving from test-server development toward live deployment.
Vystar said it completed the formation of the new R3ALM operating corporation and appointed a joint board of directors. It also said the platform is moving toward live deployment and multiple tokenization projects are under development.
More than 175 biotechs use pre-configured applications to streamline operations PLEASANTON, Calif., Oct. 7, 2026 // -- Veeva Systems (NYSE: VEEV) today announced that more than 175 emerging biotechs are establishing a technology foundation with Veeva Basics. Biotechs are launching pre-configured and pre-validated Veeva
LifeStance Health Gr (NASDAQ: LFST ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary LifeStance Health Gr reported a strong second
Niagen Bioscience (NASDAQ: NAGE ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Niagen Bioscience Inc. reported
Sanofi (NASDAQ: SNY ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Sanofi delivered a stro
On Wednesday, Kura Oncology (NASDAQ: KURA ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Kura Oncology reported $9.1 million in n
Dr Reddy's Laboratories (NYSE: RDY ) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Dr Reddy's Laboratories reported a 5.6%
Replimune agrees on FDA approval path, sending shares higher. The deal paves the way for potential future approvals.